Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides

ConclusionsThe first signal of stimulant CV safety concerns was followed by varying responses depending on the outcome measure used, suggesting that patients and physicians responded at different times after the publicity of safety concerns. Clinical consequences of the changes are uncertain. Copyright © 2015 John Wiley & Sons, Ltd.

Source: Pharmacoepidemiology and Drug Safety - November 23, 2015 Category: Drugs & Pharmacology Authors: Chih‐Ying Chen, Regina Bussing, Abraham G. Hartzema, Jonathan J. Shuster, Richard Segal, Almut G. Winterstein Tags: Original Report Source Type: research